Navigation Links
Gateway Genomics Announces Expanding Office and Research Space to Accommodate Increased Demand for SneakPeek DNA Test
Date:5/14/2019

Gateway Genomics, a leading developer of prenatal and pediatric genetic tests, announces an office expansion, effectively doubling its space from 2,500 to 5,000 square feet.

“This past year has seen exponential growth for the sales of our SneakPeek Early Gender DNA tests,” says Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home test, which is mailed directly to our customers who self-collect a blood sample and mail it back to our labs, has doubled in revenue, both domestically and in Canada and the UK. SneakPeek Clinical, which is administered by a health professional, is now offered in more than 250 medical facilities in the United States. This puts us in the great position of having to acquire additional space to accommodate increased lab throughput and staff headcount.”

The office expansion enables better shipping and delivery staging for the company, which packages and sends SneakPeek test kits directly to its at-home customers and clinical partners. It also triples the size of the on-site SneakPeek Lab, which operates six days a week and now has the capacity to process 300,000 tests annually.

“2019 and 2020 promise to be pivotal years for the company,” continues Mr. Jacob. “We’re exploring offering SneakPeek in Australia, New Zealand, and additional countries in Europe. More than 250 facilities in the U.S. now offer SneakPeek Clinical, and many more locations are being added on a monthly basis. Additionally, we will be finalizing years of research to launch our next generation of products that will let families gain insight into the characteristics of their future child. Our expanded facility will provide more space for collaboration and innovation as we introduce new products and grow our team.”

The company remains in its La Jolla, California location, effectively expanding into an adjoining office. The larger space is equipped to support projected sales growth through 2020, with expanded production capacity, lab facilities, and office staff.

Gateway Genomics will be in booth #139 at the American College of Nurse-Midwives (ACNM) annual meeting in Washington, D.C. to present the SneakPeek Clinical test from May 19-21. For more information, visit http://www.gatewaygenomics.org/events.

About Gateway Genomics

Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 100,000 SneakPeek Early Gender DNA tests have been provided to help new moms bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.

Read the full story at https://www.prweb.com/releases/gateway_genomics_announces_expanding_office_and_research_space_to_accommodate_increased_demand_for_sneakpeek_dna_test/prweb16309489.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Voxx Analytics Announces Release of Voxx.Gateway for Medical Device and Early-Stage Life Science Companies
2. Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets
3. Gateway Analytical to Present Latest Research at the Drug Delivery to the Lungs Conference in Edinburg, Scotland
4. Labome: The Gateway to the Perfect Antibody -- Labome Antibody Review Database Has Now Reached 10,000 Peer-Reviewed Formal Publications
5. Jeffrey Toobin Joins Gateway Public Schools for the 2013 Matters of the Mind Luncheon
6. Murrieta Genomics Inaugural Advisory Board Announced - Science, Technology, Business and Operations Leaders to Advise Incubator Companies
7. Murrieta Genomics and SeqOnce Biosciences Team to Simplify and Commercialize Next Generation Sequencing Sample Preparation
8. DNAnexus Sponsors Educational Webinar to Highlight Advancements in Pediatric Cancer Genomics
9. Rosalind™ Launches the Next Era of Genomics
10. Phase Genomics Announces Availability of Kit-based ProxiMeta™ Hi-C Metagenome Deconvolution
11. Rosalind™ Launches the Next Era of Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally recognized ... provides Object exclusive ownership and commercialization rights to a full spectrum of botulinum ...
(Date:5/22/2019)... ... May 22, 2019 , ... Artemis (formerly Agrilyst), ... million Series A funding round co-led by Astanor Ventures and Talis ... Fund and iSelect Fund . The company has raised $11.75m to date ...
Breaking Biology Technology:
(Date:7/9/2019)... , ... July 08, 2019 , ... ... footprint in the biotechnology hub of Cambridge, MA. This expansion strengthens KMK’s presence ... market research , and sales force effectiveness consulting for the biotechnology ...
(Date:6/25/2019)... ... June 25, 2019 , ... ActX has ... data, easily available from 23andMe, customers can get access to professionally reviewed genetic ... for both 23andMe Ancestry and Health + Ancestry customers., With the ActX + ...
(Date:6/18/2019)... ... 18, 2019 , ... Cirrascale Cloud Services ®, a ... as part of its dedicated, multi-GPU, deep learning cloud offerings. Powered by the ... NVIDIA® Quadro RTX™ GPUs for up to 260 teraflops of compute performance and ...
Breaking Biology News(10 mins):